and nongovernmental organizations to host 2 BHGI international summits. The evidence-based BHGI guidelines, developed at the 2002 Global Summit, were published in 2003 as a theoretical treatise on international breast health care. These guidelines were then updated and expanded at the 2005 Global Summit into a fully comprehensive and flexible framework to permit incremental improvements in health care delivery, based on outcomes, cost, cost-effectiveness, and use of health care services. (JNCCN 2007;5:348-355) Breast cancer is the most common cancer among women globally and is the most likely reason that women die of cancer. Breast cancer is newly diagnosed in more than 1.1 million women each year and represents more than 10% of all new cancer cases in women. Annually, breast cancer causes more than 410,000 deaths and accounts for approximately 1.6% of all female deaths worldwide.
Breast cancer is the most common cancer among women globally and is the most likely reason that women die of cancer. Breast cancer is newly diagnosed in more than 1.1 million women each year and represents more than 10% of all new cancer cases in women. Annually, breast cancer causes more than 410,000 deaths and accounts for approximately 1.6% of all female deaths worldwide. 1, 2 Countries with established and adequately funded health care systems have higher rates of breast cancer diagnosis but also higher rates of breast cancer survival. 3 In low-resource regions, breast cancer is becoming an increasingly urgent problem, with incidence rates rising by up to 5% per year. 4 Despite the common impression that breast cancer is a disease of wealthy countries, most breast cancer deaths occur in developing countries. 5 Physicians working in limited-resource environments may be forced to make decisions contrary to their best medical knowledge. Less-than-optimal solutions may be offered when diagnostic or treatment resources are limited or lacking. Lack of radiotherapy facilities, for instance, prevents breast conservation for invasive breast cancer, 6 and the lack of chemotherapy agents and infrastructure may make delivering cytotoxic chemotherapy in the adjuvant or metastatic setting impossible or unsafe.
The constraint of limited resources generates tension for clinicians who cannot offer gold standard treatments to any or all patients. This tension is amplified by clinicians' added responsibility for managing an inadequate, fixed amount of resources from an insufficient cancer program budget. For example, should a clinician treat 10 patients with an older, less expensive chemotherapy regimen or 2 patients with a newer, more efficacious, but also more expensive regimen? Thus, it is important to identify which resources commonly applied in resource-abundant countries are optimally used in limited-resource populations, where patients commonly present with more advanced disease at diagnosis. Furthermore, it is important to recognize that resource limitations for cancer care are not necessarily defined by national, regional, or state boundaries. Within the United States, significant disparities in the provision of health care exist based on both geographic regions and racial and ethnic goups. 
Resource Allocation in Limited-Resource Countries
Rational health care requires rationing resources in most of the world. To Westerners, this concept may seem draconian or unethical. Do the ethical and moral obligations of providing health care not require clinicians to provide everything they can for their patients? This perspective might suggest that writing guidelines for care in limited-resource environments resembles authorizing substandard care. Nothing could be further from the truth.
First attempts at establishing a cancer treatment program require simple and highly efficacious therapies. Key treatment alternatives are discussed, considering the relative costs and efficacies and the expected availability of resources and personnel to implement the program's policies. Flexibility in recommendations is important because the heterogeneity in social, economic, and health-system barriers to improvement among countries, or even among regions of the same country, makes universal recommendations impractical.
It would be easy to assume that Western methods of breast cancer diagnosis and treatment should directly translate to application in low-and middle-income countries. However, this assumption is not necessarily correct and does not take into account the historic development of modern techniques. Some tools considered indispensable by Western standards are less useful in limited-resource environments because the more advanced stage of disease at diagnosis makes them less relevant. Standards of care are defined by the environment in which they are practiced. Similarly, the need for tools depends on the population in which the tools are used. The degree to which specific technologies are useful depends partially on the prevalence and stage of disease at presentation.
One example of a tool considered indispensable in developed countries that may have considerably less usefulness in mid-and low-level resource countries is diagnostic mammography for breast conserving therapy (BCT). Diagnostic mammography is generally considered mandatory for BCT 10 because early BCT trials required preoperative diagnostic mammography for entry. 11, 12 In contrast, Nadkarni et al. 13 reviewed their institutional experience in Mumbai, India to assess how often diagnostic mammography added to clinical assessment in the selection of patients for BCT. During 2004, 307 patients underwent modified radical mastectomy and 428 underwent BCT at Tata Memorial Hospital. The investigators found that if mammography had not been performed in these 735 patients, BCT would have been erroneously performed in only 38 (5%; 13 with impalpable multicentric disease and 25 patients with extensive microcalcifications). The remaining patients were correctly assessed as needing BCT or mastectomy based on clinical assessment by an experienced surgeon.
Furthermore, had BCT been attempted in the 38 patients with clinically occult disease, most (if not all) of the errors would have been recognized and rectified postoperatively based on positive surgical margins. Thus, although diagnostic mammography has been considered indispensable for BCT on historical grounds, this belief was not validated in a limited-resource setting, where patients are presenting almost exclusively with clinically detectable disease.
Nadkarni et al. 13 are not arguing that diagnostic mammography is without value, nor do they suggest that it should be eliminated as a tool in their country. Rather, they point out that women in limited-resource countries being treated in facilities that offer surgery, radiotherapy, and adequate pathology services should not be denied BCT simply because they lack diagnostic mammography. The findings of this important study do not translate to populations where screening mammography is available, and hence where a much larger fraction of patients are diagnosed with clinically occult disease. However, the findings of this study are of great relevance to developing countries that are struggling with resource allocation as they build health care infrastructure. The aspiration of those countries is ultimately to offer services similar to those widely available in affluent countries. In reality, this infrastructure must be built step by step and will experience competition for limited resources from a wide variety of other health care problems.
Cancer Care Guidelines Addressing Limited-Resource Countries
Early detection and comprehensive cancer treatment play synergistic roles in improving the outcomes of patients with breast cancer. In economically developed countries, guidelines outlining optimal approaches to early detection, diagnosis, and treatment of breast cancer have been defined and disseminated. [14] [15] [16] The National Comprehensive Cancer Network (NCCN) has developed authoritative, evidence-based algorithmic guidelines for breast cancer screening and diagnosis 17 and breast cancer treatment. 18 However, in 2002, the World Health Organization warned of the limited value of guidelines that do not consider economics when applied in resource-constrained countries. 19 Guidelines that consider implementation costs and provide guidance as to how an existing system could be improved incrementally toward an ideal delivery system based on available resources will be of greatest use to resourcelimited countries.
The guidelines development process for countries with limited resources must offer a practical solution to the implausibility of applying breast cancer guidelines developed for high-resource countries to countries with limited resources. Guidelines from high-resource countries may be inappropriate for numerous reasons, including inadequate numbers of trained health care providers; inadequate diagnostic and treatment infrastructure, such as operating rooms, radiation therapy equipment, pathology, pharmacy, infusion centers, and microbiology laboratories; lack of drugs; lack of radiographic film; inadequate transportation systems; and cultural, societal, or religious barriers to women accessing the health care system. Thus, in a country with limited resources, many barriers exist between the average patient and the level of care dictated by guidelines applicable to highresource settings.
The Breast Health Global Initiative
Established in 2002, the Breast Health Global Initiative (BHGI) created an international alliance to develop evidence-based guidelines useful in lowand middle-income countries to improve breast health outcomes. The BHGI serves as a program for developing international guidelines and as a hub for clinicians, government health agencies, and advocacy groups seeking to translate guidelines into policy and practice. The founding co-sponsors of the BHGI, the Based on the consensus model developed by the NCCN, 20 the first evidence-based guidelines were developed at the 2002 BHGI Global Summit, "International Breast Health-Care Guidelines for Countries with Limited Health-Care Resources," to define approaches by which countries of low-and midlevel income can foster programmatic improvement in early detection, diagnosis, and treatment of breast cancer. These guidelines, which were published in 2003, outline principles for programmatic improvement in breast health services as applied to low-and middle-income countries. 7, [21] [22] [23] At the 2002 Global Summit, 2 axioms were adopted as principles for guideline development. First, all women should have the right of access to health care, but considerable challenges exist in implementing breast health care programs when resources are limited. Second, all women have the right to receive education about breast cancer, but the education must be culturally appropriate and targeted and tailored to the specific population. Although some countries of the world may not fully accept these axioms, the panelists believe their adoption was a key starting point in guideline development.
In countries with limited resources, most women present with locally advanced or metastatic breast cancer. Based on evidence-based review and consensus discussion, 4 core observations were made at the 2002 summit: 1) advanced breast cancer has a poor prognosis and is the most resource-intensive to treat and efforts aimed at early detection can reduce the disease stage at diagnosis, potentially improving the odds of survival and cure and enabling simpler and more cost-effective treatment; 2) programs must be built that are specific to each country's unique situation; 3) developing cancer centers can be a costeffective way to deliver breast cancer care to some women when delivering this care to women nationwide is not yet possible; and 4) collecting data on breast cancer is imperative for deciding the best way to apply resources and for measuring progress.
Summary of Updated Results from the 2005 BHGI Global Summit
At the 2005 BHGI Global Summit, the guidelines were updated and expanded into a flexible, fully comprehensive framework for improving the quality of health care delivery based on outcomes, cost, costeffectiveness, and use of health care services. Held January [12] [13] [14] [15] 2005 , and hosted by the Office of International Affairs of the National Cancer Institute in Bethesda, Maryland, the 2005 BHGI Global Summit convened 67 international experts representing 33 countries and 5 continents to define specific "best practices with limited resources" (www.fhcrc.org/science/ phs/bhgi). The 2005 guidelines addressed 1) early detection and access to care, 24 2) diagnosis and pathology, 25 3) cancer treatment and allocation of resources, 8 and 4) health care systems and public policy. 26 The stepwise, systematic approach to health care improvement outlined by the 2005 BHGI panels involved a tiered system of resource allotment defined using 4 levels-basic, limited, enhanced, and maximal-based on the contribution of each resource toward improving clinical outcomes:
• Basic level: Core resources or fundamental services absolutely necessary for any breast health care system to function. By definition, a health care system lacking any basic level resource would be unable to provide breast cancer care to its patient population. Basic-level services are typically applied in a single clinical interaction.
• Limited level: Second-tier resources or services that produce major improvements in outcome, such as increased survival, but that are attainable with limited financial means and modest infrastructure.
Limited-level services may involve single or multiple clinical interactions. • Enhanced level: Third-tier resources or services that are optional but important. Enhanced-level resources may produce minor improvements in outcome but increase the number and quality of therapeutic options and patient choice. • Maximal level: High-level resources or services that may be used in some high-resource countries or be recommended by breast care guidelines that assume unlimited resources. These should be considered a lower priority than those in the basic, limited, or enhanced categories on the basis of extreme cost or impracticality for broad use in a resource-limited environment. To be useful, maximal-level resources typically depend on the existence and functionality of all lower-level resources.
Each panel created tables prioritizing resources to facilitate programmatic improvement in breast cancer early detection (Table 1) , diagnosis and pathology (Table  2) , treatment (Tables 3-6) , and health care systems (Table 7 ), each stratified for resource level of basic, limited, enhanced, and maximal. This stratified matrix scheme assumes incremental resource allocation and implementation. For example, the limited level assumes that a setting already has all of the resources and program components recommended for the basic level.
Although the long-term goal may be achieving the maximal level in certain areas (e.g., the implementation of population-based mammographic screening), most limited-resource countries must address more fundamental needs before maximal-level resources or services can be realistically applied. Multiple resource levels may, and often do, coexist within a country, region, or even individual health care facility. A country may have community clinics that provide care at the basic level, regional hospitals that provide care at the limited level, and a national cancer center that provides care at the enhanced or maximal level. Because circumstances vary so widely around the world, decisions about how to plan the overall structure of a national breast program must be made on a country-by-country, region-byregion, or facility-by-facility basis. During the BHGI summits, some key points were identified. 27 First, early breast cancer detection improves outcome cost-effectively, assuming treatment is available. 28 Second, the efficacy of early-detection programs requires public education to foster active individual participation in diagnosis and treatment. 29 Third, clinical breast examination combined with diagnostic breast imaging (breast sonography with or without diagnostic mammography) can facilitate costeffective tissue sampling techniques for cytologic or histologic diagnosis. 25 Fourth, BCT with partial mastectomy and radiation requires more health care resources and infrastructure than mastectomy but can be provided in a thoughtfully designed limitedresource setting. 6 Fifth, the availability and administration of systemic therapy are critical to improving survival. Sixth, estrogen-receptor testing allows patient selection for hormonal treatments (tamoxifen, oophorectomy), which is better for patient care and allows proper distribution of services. Seventh, chemotherapy, which requires substantial allocation of resources and infrastructure, is needed to treat locally advanced breast cancer, which represents the most common clinical presentation of disease in lowresource countries. Furthermore, when chemotherapy is unavailable, patients presenting with locally advanced, hormone receptor-negative cancers can receive only palliative therapy. 8 The 2005 BHGI guidelines can be used to communicate programmatic needs to hospital administrations, government officials, and health care ministries. The thesis of the BHGI is that these guidelines create a framework for change by defining practical pathways through which breast cancer care can be improved in an incremental and cost-effective fashion. 27 However, guidelines themselves do not improve outcomes for women; implementation is the critical step through which their value can be measured. The results of pilot research and demonstration projects must be studied and reported to determine guideline effectiveness and to create evidence to guide and facilitate guideline implementation in other settings. The next BHGI Global Summit, which will be held in Budapest, Hungary, in October 2007, will be directed at defining the next steps for programmatic implementation of BHGI guidelines in limited-resource countries. In this way, the BHGI endeavors to help women cope with and survive the ravages of the most common cancer among women.
